Development and validation of a nomogram to predict the risk of potentially inappropriate medication use in older lung cancer outpatients with multimorbidity-Reference-Cited by-同舟云学术

Development and validation of a nomogram to predict the risk of potentially inappropriate medication use in older lung cancer outpatients with multimorbidity

Published:2023-02-22 Issue:8 Volume:22 Page:725-732
ISSN:1474-0338
Container-title:Expert Opinion on Drug Safety
language:en
Short-container-title:Expert Opinion on Drug Safety

Author:

Tian Fangyuan¹²^ORCID,Chen Zhaoyan¹,Wu Bin¹

Affiliation:

1. Department of Pharmacy, National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University, Chengdu, Sichuan, China

2. Department of Epidemiology and Health Statistics, West China School of Public Health and West China Fourth Hospital, Sichuan University, Chengdu, Sichuan, China

Funder

the Sichuan Geriatrics Healthcare Program

Sichuan Science and Technology Program

Publisher

Informa UK Limited

Subject

Pharmacology (medical),General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14740338.2023.2183191

Reference44 articles.

1. Changing profiles of cancer burden worldwide and in China: a secondary analysis of the global cancer statistics 2020

2. Global Cancer Observatory: Cancer Today. International agency for research on cancer; 2020. Available from: https://gco.iarc.fr/today/data/factsheets/cancers/15-Lung-fact-sheet.pdf. Accessed 2022 Mar 23

3. Increasing Trends of Polypharmacy and Potentially Inappropriate Medication Use in Older Lung Cancer Patients in China: A Repeated Cross-Sectional Study

4. Lung Cancer Statistics

5. Treatment of older patients with advanced non-small cell lung cancer: A challenge

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Polypharmacy, potentially inappropriate medications, and drug-drug interactions in older COVID-19 inpatients;BMC Geriatrics;2023-11-25